Hansen, M Yaloumis, L Kircik, and Linda F. Butler, I FI Kuo, K Sun, and M Lebwohlġ7754 Treatment success in mild psoriasis patients with fixed-combination calcipotriene and betamethasone dipropionate foam: Results from the PSO-FAST trial, K A. Stein Goldġ7753 Analysis of 24-week response to ruxolitinib cream for the treatment of vitiligo based on patient demographics and clinical characteristics, Iltefat Hamzavi, J E. Tyring, A Tallman, and A Armstrongġ6520 Continuing medical education on acne improves dermatologists’ knowledge and competence on patient management, S J. One center experience, T Esakia, T Melkadze, K Tsiklauri, E Mariamidze, S Tsitsilashvili, N Otkhozoria, M Abuladze, N Jokhadze, and Nino Balanchivadzeġ6392 Efficacy of tapinarof cream by body region in subjects with plaque psoriasis in a phase 2b randomized controlled study, R Bissonnette, Linda F. Silverbergġ632P At home androgen deprivation therapy for patients with prostate cancer during the COVID-19 pandemic. Cameron, D Williams, P Biswas, and H Valdezġ5821 Efficacy and safety of carbon dioxide laser excision in hidradenitis suppurativa: Experience from an urban academic medical center, Taylor Braunberger, P Vakharia, Shanthi Narla, C Nicholson, and Ashley Parks-Millerġ5838 Autoimmune comorbidities of psoriasis in US adults and children, Shanthi Narla and J I. Stein Gold, S Kwatra, S Tatulych, C Nduaka, M C. Hamzaviġ5517 Eczema Area and Severity Index 90 (EASI-90) responder rates with abrocitinib and relationship with quality of life (QoL) and itch in patients with moderate to severe atopic dermatitis: Results from a randomized phase 3 clinical trial, G Yosipovitch, T Bieber, Linda F. Lyons, Raheel Zubair, Angela Parks-Miller, Indermeet Kohli, and Iltefat H. PharMd, and S Harrisġ5485 Evaluating the safety and efficacy of intense pulsed light with radiofrequency in US patients with hidradenitis suppurativa: A split-body study, Alexis B. Stein Gold, G Martin, R Pillai, and E Gueninġ5324 Long-term management of moderate to severe plaque psoriasis: Maintenance of treatment success following cessation of fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in patients with baseline body surface area of 6%-12%, Linda F. Saenz, and F Ahmadġ5211 Treatment of moderate to severe acne with once-daily tazarotene 0.045% lotion in males: Pooled analysis of two phase 3 studies, J S. Stein Gold, F Cook-Bolden, L Eichenfield, E Tanghetti, M Graeber, A A. Nahmġ3882 Trifarotene 50 μg/g cream: An effective and safe treatment for moderate facial and truncal acne, J D. Del Rosso, L Kircik, N Bhatia, D Hooper, and W K. Limġ3509 Integrated safety analysis of FMX103 1.5% topical minocycline foam for the treatment of moderate to severe papulopustular rosacea: Results from two phase 3 studies, Linda F. Gadgeelġ3303 Prevalence of photodermatoses in the general dermatology clinic of four academic medical centers: A multicenter retrospective analysis of 1080 patients over a 10-year period, Tasneem F. Mokġ317P Renal toxicity in black patients with non-squamous non-small cell lung cancer treated with combination platinum-pemetrexed-pembrolizumab therapy, Nino Balanchivadze, Zeinab Nasser, Muhammad Shahid, Cortney McKay, Pin Li, Ryann Sohaney, and Shirish M. Gandara, E Schleifman, J Wang, and T S.K. Barrios, M Yamaguchi, E Dansin, P Danchaivijitr, M Johnson, S Novello, D R. Shagan, E Felip, A Morabito, P Cheema, M C. Garon, D Hong, R Shazer, X Yan, L Latven, and K Heġ281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C, R Dziadziuszko, S Peters, Shirish M. Waterhouse, D Richards, A Pham, R Jotte, E B. Smith, Mariam Ayyash, and Louise O'Brienġ191O MRTX-500: Phase II trial of sitravatinib (sitra) + nivolumab (nivo) in patients (pts) with non-squamous (NSQ) non-small cell lung cancer (NSCLC) progressing on or after prior checkpoint inhibitor (CPI) therapy, T A. Pitts, and Luisa Bazanġ156 Social determinants of sleep in black pregnant women, D'Angela S. 102 The efficacy of a pilot program for obstructive sleep apnea screening in pregnancy, Nicolina Smith, Matthew Floyd, Roopina Sangha, Philip Cheng, Angela Osborne, D'Angela S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |